Metraipolis › archive › dc_de0bb939bb1b

Effectiveness and safety of vedolizumab in real-world studies in Asian patients with inflammatory bowel disease: a systematic review and meta-analysis — Europe PMC PMID:42277696

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42277696
DOI
10.1186/s12876-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-31T13:16:57.046Z
SHA-256 of the archived text
cc2e2e0c7c9de4f29c27ea99180d3602d48472f6a862ef06b25b789801c407d4
Stable URL of this page
https://metraipolis.com/documento/dc_de0bb939bb1b

How to cite

Effectiveness and safety of vedolizumab in real-world studies in Asian patients with inflammatory bowel disease: a systematic review and meta-analysis — Europe PMC PMID:42277696 — Europe PMC (en), https://europepmc.org/article/MED/42277696 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de0bb939bb1b (Metraipolis archive dc_de0bb939bb1b, sha256 cc2e2e0c7c9de4f29c27ea99180d3602d48472f6a862ef06b25b789801c407d4)
BibTeX
@misc{dcde0bb939bb1b,
  title = {Effectiveness and safety of vedolizumab in real-world studies in Asian patients with inflammatory bowel disease: a systematic review and meta-analysis — Europe PMC PMID:42277696},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42277696},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de0bb939bb1b; sha256 cc2e2e0c7c9de4f29c27ea99180d3602d48472f6a862ef06b25b789801c407d4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42277696. Agents can read the archived copy with the MCP tool read_document.